High- versus low-dose ACE inhibition in chronic heart failure - A double-blind, placebo-controlled study of imidapril

被引:90
作者
van Veldhuisen, DJ
Genth-Zotz, S
Brouwer, J
Boomsma, F
Netzer, T
Man In't Veld, AJ
Pinto, YM
Lie, KI
Crijns, HJGM
机构
[1] Univ Groningen Hosp, Thoraxctr, Dept Cardiol, NL-9700 RB Groningen, Netherlands
[2] Johannes Gutenberg Univ Clin, Med Clin 2, Mainz, Germany
[3] Univ Hosp Dijkzigt, COEUR, Dept Internal Med 1, Rotterdam, Netherlands
[4] Merck KGaA, Clin Res, Darmstadt, Germany
[5] Univ Groningen, Inst Clin Pharmacol, Groningen, Netherlands
[6] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands
关键词
D O I
10.1016/S0735-1097(98)00464-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. To determine dose-related clinical and neurohumoral effects of angiotensin-converting enzyme (ACE) inhibitors in patients with chronic heart failure (CHF), we conducted a double-blind, placebo-controlled, randomized study of three doses (2.5 mg, 5 mg and 10 mg) of the long-acting ACE inhibitor imidapril. Background. The ACE inhibitors have become a cornerstone in the treatment of CHF, but whether high doses are more effective than low doses has not been fully elucidated, nor have the mechanisms involved in such a dose-related effect. Methods. In a parallel group comparison, the effects of three doses of imidapril were examined. We studied 244 patients with mild to moderate CHF (New York Heart Association class II-III: +/-80%/20%), who were stable on digoxin and diuretics. Patients were treated for 12 weeks, and the main end points were exercise capacity and plasma neurohormones. Results. At baseline, the four treatment groups were well-matched for demographic variables. Of the 244 patients, 25 dropped out: 3 patients died, and 9 developed progressive CHF (3/182 patients on imidapril vs. 6/62 patients on placebo, p < 0.05). Exercise time increased 45 s in the 10 mg group (p = 0.02 vs. placebo), but it did not significantly change in the 5 mg (+16 s), and 2.5-mg (+11 s) imidapril group, compared to placebo (+3 s). Physical working capacity also increased in a dose-related manner. Plasma brain and atrial natriuretic peptide decreased (p < 0.05 for linear trend), while (nor)epinephrine, aldosterone and endothelin were not significantly affected. Renin increased in a dose-related manner, but plasma ACE activity was suppressed similarly (+/-60%) on all three doses. Conclusions. Already within 3 months after treatment initiation, high dose ACE inhibition (with imidapril) is superior to low-dose. This is reflected by a more pronounced effect on exercise capacity and some of the neurohormones, but it does not appear to be related to the extent of suppression of plasma ACE. (J Am Coll Cardiol 1998;32:1811-8) (C)1998 by the American College of Cardiology.
引用
收藏
页码:1811 / 1818
页数:8
相关论文
共 40 条
[1]  
*ATLAS INV, 1998, EUR HEART J, V19, P142
[2]   STABILITY OF HUMAN PLASMA ATRIAL-NATRIURETIC-PEPTIDE DURING STORAGE AT -80-DEGREES-C [J].
BHAGGOE, UM ;
BOOMSMA, F ;
ADMIRAAL, PJJ ;
MANINTVELD, AJ ;
SCHALEKAMP, MADH .
CLINICA CHIMICA ACTA, 1993, 223 (1-2) :179-184
[3]   Differential inhibition of plasma versus tissue ACE by utibapril: Biochemical and functional evidence for inhibition of vascular ACE activity [J].
Buikema, H ;
Pinto, YM ;
vanGeel, PP ;
Rooks, G ;
deLangen, CDJ ;
deGraeff, PA ;
vanGilst, WH .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1997, 29 (05) :684-691
[4]  
CLELAND JGF, 1994, BRIT HEART J, V72, pS106
[5]   Interruption of the progression of heart failure: Are ACE inhibitors the solution? [J].
Coats, A .
CARDIOLOGY, 1996, 87 :11-15
[6]   Drug therapy - The management of chronic heart failure [J].
Cohn, JN .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (07) :490-498
[7]   Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care [J].
Cowie, MR ;
Struthers, AD ;
Wood, DA ;
Coats, AJS ;
Thompson, SG ;
PooleWilson, PA ;
Sutton, GC .
LANCET, 1997, 350 (9088) :1349-1353
[8]   CONCENTRATIONS OF ANGIOTENSIN-CONVERTING ENZYME IN TISSUES OF RAT [J].
CUSHMAN, DW ;
CHEUNG, HS .
BIOCHIMICA ET BIOPHYSICA ACTA, 1971, 250 (01) :261-+
[9]   Hormonal and renal differences between low dose and high dose angiotensin converting enzyme inhibitor treatment in patients with chronic heart failure [J].
Davidson, NC ;
Coutie, WJ ;
Webb, DJ ;
Struthers, AD .
HEART, 1996, 75 (06) :576-581
[10]  
de Vries RJM, 1997, EUR HEART J, V18, P1921